SHENZHEN INTERNATIONAL INSTITUTE FOR BIOMEDICAL RES has a total of 13 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2017. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SYZ CELL THERAPY CO, ZHAOQING DAHUANONG BIOLOGIC PHARMACEUTICAL CO LTD and NOUSCOM AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Enzymes | |
#5 | Therapeutic chemical compounds | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Roizman Bernard | 10 |
#2 | Mallon Stephen | 5 |
#3 | Weichselbaum Ralph R | 5 |
#4 | Shu Minfeng | 5 |
#5 | Zhou Grace | 4 |
#6 | Liu Yonghong | 3 |
#7 | Chen Xinhai | 2 |
#8 | Zhou Xusha | 1 |
#9 | Lu Ruitao | 1 |
#10 | Zhou Grace Guoying | 1 |
Publication | Filing date | Title |
---|---|---|
CN111330007A | Composition for enhancing anti-tumor immune response and application thereof | |
CN111714482A | Application of small molecular compound in improving host pathogenic bacteria removing capability and application in preparing anti-pathogenic bacteria infection medicine | |
CN111714495A | Application of small molecular compound in improving host pathogenic bacteria removing capability and application in preparing anti-pathogenic bacteria infection medicine | |
WO2020132946A1 | Pharmaceutical compositions, kits and methods for treating tumors | |
CA3052882A1 | Methods and compositions for treatment of ionizing radiation resistant tumors | |
EP3610004A1 | Pum 1 protein as target for virus inhibition |